10-K Decoder · All companies

ALX Oncology Holdings Inc.

ALXO · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$104M−$142M+27.0%
Net income−$102M−$135M+24.6%

Questions

What was ALX Oncology's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
Was ALX Oncology profitable in FY2025?
No: net income was −$102M and operating income −$104M in FY2025.